Chemical Compound

DOLUTEGRAVIR SODIUM

CAS Registry Number 1051375-19-9
DOLUTEGRAVIR SODIUM chemical structure
Primary Record

DOLUTEGRAVIR SODIUM

In stock
5,263 g
Purity
98.7 %
CAS
1051375-19-9

Compound Identifiers & Properties

CAS
1051375-19-9
PubChem CID
46216142
SMILES
C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]
Canonical SMILES
C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12.[Na+]

Names & Synonyms

  • DOLUTEGRAVIR SODIUM
  • Tivicay
  • Dovato
  • 1051375-19-9
  • Dolutegravir
  • Dolutegravir sodium salt
  • Dolutegravir (sodium)
  • Tivicay (TN)
  • TIVICAY PD
  • GSK1349572 sodium
  • UNII-1Q1V9V5WYQ
  • GSK1349572 sodiuM salt
  • Dolutegravir sodium [USAN]
  • 1Q1V9V5WYQ
  • RefChem:56965
  • Alendronate sodium hydrate
  • GSK 1349572A
  • C20H18F2N3NaO5
  • CHEBI:76007
  • Dolutegravir Sodium ( API)
  • GSK-1349572A
  • GSK1349572A
  • Tivicay (Dolutegravir Sodium)
  • MFCD28405599
  • orb1305676
  • CHEMBL1213165
  • SCHEMBL19859120
  • SCHEMBL29363090
  • Dolutegravir sodium (JAN/USAN)
  • DOLUTEGRAVIR SODIUM [JAN]
  • DTXCID001513426
  • DTXSID201027849
  • GLXC-10568
  • BCP11890
  • EX-A1694
  • DOLUTEGRAVIR SODIUM [WHO-DD]
  • HY-13238A
  • s4642
  • DOLUTEGRAVIR SODIUM SALT [MI]
  • AKOS025396662
  • ACN-041354
  • CS-3496
  • GSK1349572
  • JULUCA COMPONENT DOLUTEGRAVIR SODIUM
  • KS-00000T34
  • TRIUMEQ COMPONENT DOLUTEGRAVIR SODIUM
  • DOLUTEGRAVIR SODIUM [ORANGE BOOK]
  • AS-57143
  • DA-62992
  • B5856
  • D10113
  • A921951
  • F799859
  • sodium;(3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate
  • Q27145679
  • Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
  • B2693-463509
  • 2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZINE-9-CARBOXAMIDE, N-((2,4-DIFLUOROPHENYL)METHYL)-3,4,6,8,12,12A-HEXAHYDRO-7-HYDROXY-4-METHYL-6,8-DIOXO-, SODIUM SALT (1:1), (4R,12AS)-
  • 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, sodium salt (1:1), (4R,12aS)-; Dolutegravir sodium; Dolutegravir sodium salt; GSK 1349572A; GSK 1349572A
  • DTG
  • GSK1349572sodiuMsalt;DOLUTEGRAVIRSODIUM;GSK1349572A;Dolutegravir sodiuM salt;Dolutegravir SodiuM ( API)
  • SODIUM (4R,12AS)-9-(((2,4-DIFLUOROPHENYL)METHYL)CARBAMOYL)-4-METHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZIN-7-OLATE
  • Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate;Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
  • sodium (4R,12aS)-9-[(2,4-difluorobenzyl)carbamoyl]-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate